Armata Pharmaceuticals, Inc. (ARMP)
2.98
-0.19
(-5.99%)
USD |
NYAM |
Nov 19, 16:00
Armata Pharmaceuticals Free Cash Flow : -26.86M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -26.86M |
| June 30, 2026 | -25.79M |
| March 31, 2026 | -24.47M |
| December 31, 2025 | -26.30M |
| September 30, 2025 | -27.43M |
| June 30, 2025 | -32.09M |
| March 31, 2025 | -36.28M |
| December 31, 2024 | -39.43M |
| September 30, 2024 | -42.09M |
| June 30, 2024 | -46.08M |
| March 31, 2024 | -46.82M |
| December 31, 2023 | -55.57M |
| September 30, 2023 | -55.09M |
| June 30, 2023 | -53.52M |
| March 31, 2023 | -50.52M |
| December 31, 2022 | -34.69M |
| September 30, 2022 | -33.49M |
| June 30, 2022 | -27.41M |
| March 31, 2022 | -22.86M |
| December 31, 2021 | -24.88M |
| September 30, 2021 | -22.72M |
| June 30, 2021 | -21.14M |
| March 31, 2021 | -20.53M |
| December 31, 2020 | -19.09M |
| September 30, 2020 | -15.18M |
| Date | Value |
|---|---|
| June 30, 2020 | -15.72M |
| March 31, 2020 | -17.54M |
| December 31, 2019 | -15.81M |
| September 30, 2019 | -16.64M |
| June 30, 2019 | -14.32M |
| March 31, 2019 | -10.57M |
| December 31, 2018 | -11.50M |
| September 30, 2018 | -10.30M |
| June 30, 2018 | -8.754M |
| March 31, 2018 | -9.482M |
| December 31, 2017 | -9.25M |
| September 30, 2017 | -8.357M |
| June 30, 2017 | -10.89M |
| March 31, 2017 | -10.98M |
| December 31, 2016 | -10.87M |
| September 30, 2016 | -11.74M |
| June 30, 2016 | -11.19M |
| March 31, 2016 | -10.85M |
| December 31, 2015 | -9.991M |
| September 30, 2015 | -10.83M |
| June 30, 2015 | -10.98M |
| March 31, 2015 | -12.20M |
| December 31, 2014 | -13.77M |
| September 30, 2014 | |
| June 30, 2014 |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Lineage Cell Therapeutics, Inc. | -26.46M |
| Voyager Therapeutics, Inc. | -109.83M |
| Black Diamond Therapeutics, Inc. | -33.32M |
| Invivyd, Inc. | -134.11M |
| Elicio Therapeutics, Inc. | -36.99M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.516M |
| Cash from Investing (Quarterly) | -0.091M |
| Cash from Financing (Quarterly) | -0.028M |
| Free Cash Flow Per Share (Quarterly) | -0.0895 |
| Free Cash Flow to Equity (Quarterly) | 56.76M |
| Free Cash Flow to Firm (Quarterly) | 1.954M |
| Free Cash Flow Yield | -24.24% |